Patents by Inventor Birgit Zech

Birgit Zech has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
    Patent number: 8084457
    Abstract: The present invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, and pharmaceutical compositions containing at least one of said 4,6-di substituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: September 15, 2004
    Date of Patent: December 27, 2011
    Assignees: Lead Discovery Center GmbH, Bayer Pharma AG
    Inventors: Axel Choidas, Alexander Backes, Matt Cotten, Ola Engkvist, Beatrice Felber, Achim Freisleben, Klaus Godl, Zoltán Greff, Peter Habenberger, Doris Hafenbradl, Christian Hartung, Thomas Herget, Edmund Hoppe, Bert Klebl, Andrea Missio, Gerhard Müller, Wilfried Schwab, Birgit Zech, Jose Bravo, John Harris, Joelle Le, Jackie Macritchie, Vladimir Savic, Brad Sherborne, Don Simpson
  • Pyridinylamines
    Publication number: 20090196912
    Abstract: Described are pyridinylamines and pharmaceutically acceptable salts thereof, the use of these pyridinylamines for the prophylaxis and/or treatment of various diseases such as infectious diseases, including opportunistic infections, prion diseases immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as pharmaceutical compositions containing at least one pyridinylamine and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the pyridinylamines are disclosed.
    Type: Application
    Filed: August 1, 2005
    Publication date: August 6, 2009
    Applicant: GPC Botech AG
    Inventors: Jan Elke Eickhoff, Doris Hafenbradl, Wilfried Schwab, Matthew Cotton, Bert Matthias Kiebl, Birgit Zech, Stefan Muller, John Harris, Vladimir Savic, Jackie MacRitchie
  • Heterobicyclic Compounds as Pharmaceutically Active Agents
    Publication number: 20070275962
    Abstract: Described are heterobicyclic compounds such as 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]thiopyran 3-carboxylic acid amides, 4,7-dihydro-5H-thieno[2,3-c]pyran-3-carboxylic acid amides, or benzo[b]thiophene-3-carboxylic acid amides and pharmaceutically acceptable salts thereof, the use of these derivatives for the prophylaxis and/or treatment of various diseases such as infectious diseases, including mycobacteriainduced infections and opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, as well as compositions containing at least one heterobicyclic compound and/or pharmaceutically acceptable salts thereof. Furthermore, reaction procedures for the synthesis of the heterobicyclic compound are disclosed.
    Type: Application
    Filed: September 10, 2004
    Publication date: November 29, 2007
    Applicant: GPC BIOTECH AG
    Inventors: Anil Koul, Bert Klebl, Gerhard Muller, Andrea Missio, Wilfried Schwab, Doris Hafenbradl, Lars Neumann, Marc-Nicola Sommer, Stefan Muller, Edmund Hoppe, Achim Freisleben, Alexander Backes, Christian Hartung, Beatrice Felber, Birgit Zech, Ola Engkvist, Gyorgy Keri, Laszlo Orfi, Peter Banhegyi, Zoltan Greff, Zoltan Horvath, Zoltan Varga, Peter Marko, Janos Pato, Istvan Szabadkai, Zsolt Szekelyhid, Frigyes Waczek
  • Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
    Publication number: 20070191344
    Abstract: The present invention relates to 4,6-disubstituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, prion diseases, immunological diseases, autoimmune diseases, bipolar and clinical disorders, cardiovascular diseases, cell proliferative diseases, diabetes, inflammation, transplant rejections, erectile dysfunction, neurodegenerative diseases and stroke, and pharmaceutical compositions containing at least one of said 4,6-di substituted aminopyrimidine derivatives and/or pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: September 15, 2004
    Publication date: August 16, 2007
    Inventors: Axel Choidas, Alexander Backes, Matt Cotten, Ola Engkvist, Beatrice Felber, Achim Freisleben, Klaus Godl, Zoltan Greff, Peter Habenberger, Doris Hafenbradl, Christian Hartung, Thomas Herget, Edmund Hoppe, Bert Klebl, Andrea Missio, Gerhard Muller, Wilfried Schwab, Birgit Zech, Jose Bravo, John Harris, Joelle Le, Jackie Macritchie, Vladimir Savic, Brad Sherborne, Don Simpson